Professor of Practice (Clinical and Molecular Medicine)
Imperial College London
Claire L. Shovlin, BA (Cantab), MA, MB BChir, MRCP, FRCP FAoP is Professor of Practice (Clinical and Molecular Medicine), at Imperial College London. Based at Hammersmith campus since 1999, she has run parallel national clinical services and research programmes focussing on patients with heritable vasculopathies, particularly pulmonary arteriovenous malformations (PAVMs) and hereditary haemorrhagic telangiectasia (HHT). Laboratory research foci include identification of new pathogenic genes via the 100,000 Genomes Project, therapeutic reversal of molecular defects that cause HHT, and development of wider bioinformatics and functional tools for medicine in the post genomic era. Clinical research foci include determining disease-modifying states and quantifiable tools for evaluation. Having chaired the European Reference Network for HHT (VASCERN HHT) until Brexit, Claire currently chairs the NHS HHT Rare Disease Collaborative Network, in addition to the Genomics England Respiratory GeCIP and North Thames Genomic Medicine Service (GMS) Alliance R&D, which she represents on the NHS GMS National Research Steering Collaborative. Further details can be found at https://www.imperial.ac.uk/people/c.shovlin.